This invention relates to a solution formulation for nasal administration comprising azelastine, beclomethasone dipropionate, a co-solvent, an acid and an HFA propellant.
申请公布号
IL232944(D0)
申请公布日期
2014.07.31
申请号
IL20140232944
申请日期
2014.06.02
申请人
ZENG XIAN-MING;TEVA BRANDED PHARMACEUTICAL PRODUCTS R& D INC.;LY JADE CHING-YING;DALVI MUKUL C
